Dennis A. Wong

Omalizumab in Severe Allergic Asthma Inadequately Controlled With Standard Therapy

Nicola A. Hanania, Oral Alpan, Daniel L. Hamilos et al. · Annals of Internal Medicine · 2011 · 545 citations

A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine–refractory chronic idiopathic urticaria

Sarbjit S. Saini, Karin Rosén, Hsin-Ju Hsieh et al. · Journal of Allergy and Clinical Immunology · 2011 · 392 citations

Pharmacotherapy, Dermatology, Dose-ranging Study +5

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

Paul Emery, Gerd R Burmester, Vivian P. Bykerk et al. · Annals of the Rheumatic Diseases · 2014 · 232 citations · Full text

Churg-Strauss Syndrome in Patients Treated With Omalizumab

Michael E. Wechsler, Dennis A. Wong, Mary K. Miller et al. · CHEST Journal · 2009 · 146 citations

Clinical Finding, Autoimmune Disease, Systemic Scleroderma +6

Nasal polyps: Effects of seasonal allergen exposure

Paul K. Keith, Mary E. Conway, S A Evans et al. · Journal of Allergy and Clinical Immunology · 1994 · 88 citations

Asthma, Environmental Allergy, Nasal Polyps +5